InvestorPlace – Stock Market News, Stock Advice & Trading Tips
Recently, the cannabis market received the best hoped-for news. The Drug Enforcement Administration (DEA) announced it is moving forward with plans to reschedule marijuana from a Schedule I to a Schedule III controlled substance. While this excited many investors, the cannabis market is still a ways away from full federal legalization.
While the DEA’s announcement has led to a surge in cannabis stocks, companies facing pre-existing challenges are unlikely to see immediate improvements. In particular, these three cannabis stocks, which were struggling even before the announcement, are not well-positioned to meet the new expectations set by inflated prices.
First, we’ll detail why these stocks have struggled to find a solid footing in the cannabis industry. And, then we’ll delve into how the recent price jumps make for an excellent opportunity to…
